Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration (Q34248966)

31 July 2017

title

Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration (English)

1 reference

31 July 2017

Tadashi Yoshida

1

0 references

Patrice Delafontaine

object named as

Patrice Delafontaine

series ordinal

3

0 references

author name string

Tashfin S Huq

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

11 August 2014

1 reference

Journal of Biological Chemistry

31 July 2017

published in

1 reference

31 July 2017

volume

289

1 reference

31 July 2017

issue

38

1 reference

31 July 2017

page(s)

26239-26248

1 reference

ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II induced catabolic effect and muscle atrophy are redox dependent

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Regulation of muscle satellite cell activation and chemotaxis by angiotensin II

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Cachexia: prevalence and impact in medicine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

The AT2 receptor--a matter of love and hate

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin AT2 receptors: cardiovascular hope or hype?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin Type 2 Receptor (AT2R): A Challenging Twin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Highly coordinated gene regulation in mouse skeletal muscle regeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

International union of pharmacology. XXIII. The angiotensin II receptors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Transcriptional regulation of the mouse angiotensin II type 2 receptor gene

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176198

Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure

6 July 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

Disruption of muscle renin-angiotensin system in AT1a-/- mice enhances muscle function despite reducing muscle mass but compromises repair after injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

Skeletal muscle myoblasts possess a stretch-responsive local angiotensin signalling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT 2 receptor and the transcription factor NF‐κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

Expression, genomic organization, and transcription of the mouse angiotensin II type 2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

WITHIN-PATIENT VARIABILITY OF HORMONE AND CYTOKINE CONCENTRATIONS IN HEART FAILURE

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

Angiotensin II Induces Skeletal Muscle Wasting through Enhanced Protein Degradation and Down-Regulates Autocrine Insulin-Like Growth Factor I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

Muscle-specific expression of IGF-1 blocks angiotensin II–induced skeletal muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M114.585521

Inflammation influences vascular remodeling through AT2 receptor expression and signaling

21 January 2018

1 reference

12 December 2020

Localization of the renin-angiotensin system components to the skeletal muscle microcirculation

1 reference

12 December 2020

Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype

1 reference

12 December 2020

Notch-mediated restoration of regenerative potential to aged muscle

1 reference

12 December 2020

Angiotensin II directly inhibits protein synthesis in murine myotubes

1 reference

12 December 2020

Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure

1 reference

12 December 2020

Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I

1 reference

12 December 2020

Identifiers

DOI

10.1074/JBC.M114.585521

1 reference

31 July 2017

1 reference

31 July 2017

1 reference